BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Elhai M, Avouac J, Allanore Y. Circulating lung biomarkers in idiopathic lung fibrosis and interstitial lung diseases associated with connective tissue diseases: Where do we stand? Semin Arthritis Rheum 2020;50:480-91. [PMID: 32089354 DOI: 10.1016/j.semarthrit.2020.01.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Lin L, Zhao Y, Li Z, Li Y, Wang W, Kang J, Wang Q. Expression of S100A9 and KL-6 in common interstitial lung diseases. Medicine (Baltimore) 2022;101:e29198. [PMID: 35512076 DOI: 10.1097/MD.0000000000029198] [Reference Citation Analysis]
2 Yang S, Zhan X, Wang J, Fan Y, Ma R, Ye Q. Serum Oncomarkers in Patients with MPO-ANCA-Positive Vasculitis: Diagnostic and Prognostic Predictive Values for Interstitial Lung Disease. Lung. [DOI: 10.1007/s00408-022-00532-3] [Reference Citation Analysis]
3 Chiu Y, Chu C, Lu C, Liu F, Tang S, Chu S, Kuo S, Chen H. KL-6 as a Biomarker of Interstitial Lung Disease Development in Patients with Sjögren Syndrome: A Retrospective Case–Control Study. JIR 2022;Volume 15:2255-62. [DOI: 10.2147/jir.s352085] [Reference Citation Analysis]
4 Westermann-clark E, Soundararajan R, Fukumoto J, Patil SS, Stearns TM, Saji S, Czachor A, Hernandez-cuervo H, Breitzig M, Krishnamurthy S, Lockey RF, Kolliputi N. Matrix Metalloproteinase 7 Expression and Apical Epithelial Defects in Atp8b1 Mutant Mouse Model of Pulmonary Fibrosis. Biomolecules 2022;12:283. [DOI: 10.3390/biom12020283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Li X, Zhang T, Lv W, Wang H, Chen H, Xu Q, Cai H, Dai J. Intratracheal administration of polystyrene microplastics induces pulmonary fibrosis by activating oxidative stress and Wnt/β-catenin signaling pathway in mice. Ecotoxicol Environ Saf 2022;232:113238. [PMID: 35121255 DOI: 10.1016/j.ecoenv.2022.113238] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
6 Arron JR. Biomarkers in systemic sclerosis: mechanistic insights into pathogenesis and treatment. Curr Opin Rheumatol 2021;33:480-5. [PMID: 34420004 DOI: 10.1097/BOR.0000000000000827] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Tarantino P, Modi S, Tolaney SM, Cortés J, Hamilton EP, Kim SB, Toi M, Andrè F, Curigliano G. Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates: A Review. JAMA Oncol 2021. [PMID: 34647966 DOI: 10.1001/jamaoncol.2021.3595] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
8 Chiu YH, Spierings J, de Jong PA, Hoesein FM, Grutters JC, van Laar JM, Voortman M. Predictors for progressive fibrosis in patients with connective tissue disease associated interstitial lung diseases. Respir Med 2021;187:106579. [PMID: 34438351 DOI: 10.1016/j.rmed.2021.106579] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
9 Lagoutte P, Bettler E, Vadon-Le Goff S, Moali C. Procollagen C-proteinase enhancer-1 (PCPE-1), a potential biomarker and therapeutic target for fibrosis. Matrix Biol Plus 2021;11:100062. [PMID: 34435180 DOI: 10.1016/j.mbplus.2021.100062] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Wang Y, Chen S, Zheng S, Lin J, Hu S, Zhuang J, Lin Q, Xie X, Zheng K, Zhang W, Du G, Zhang G, Hoffmann-Vold AM, Matucci-Cerinic M, Furst DE. The role of lung ultrasound B-lines and serum KL-6 in the screening and follow-up of rheumatoid arthritis patients for an identification of interstitial lung disease: review of the literature, proposal for a preliminary algorithm, and clinical application to cases. Arthritis Res Ther 2021;23:212. [PMID: 34391465 DOI: 10.1186/s13075-021-02586-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Cabrera Cesar E, Lopez-Lopez L, Lara E, Hidalgo-San Juan MV, Parrado Romero C, Palencia JLRS, Martín-Montañez E, Garcia-Fernandez M. Serum Biomarkers in Differential Diagnosis of Idiopathic Pulmonary Fibrosis and Connective Tissue Disease-Associated Interstitial Lung Disease. J Clin Med 2021;10:3167. [PMID: 34300333 DOI: 10.3390/jcm10143167] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
12 Bao Y, Zhang W, Shi D, Bai W, He D, Wang D. Correlation Between Serum Tumor Marker Levels and Connective Tissue Disease-Related Interstitial Lung Disease. Int J Gen Med 2021;14:2553-60. [PMID: 34163223 DOI: 10.2147/IJGM.S310917] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
13 Yamashita M, Utsumi Y, Nagashima H, Nitanai H, Yamauchi K. S100A9/CD163 expression profiles in classical monocytes as biomarkers to discriminate idiopathic pulmonary fibrosis from idiopathic nonspecific interstitial pneumonia. Sci Rep 2021;11:12135. [PMID: 34108546 DOI: 10.1038/s41598-021-91407-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Shao T, Shi X, Yang S, Zhang W, Li X, Shu J, Alqalyoobi S, Zeki AA, Leung PS, Shuai Z. Interstitial Lung Disease in Connective Tissue Disease: A Common Lesion With Heterogeneous Mechanisms and Treatment Considerations. Front Immunol 2021;12:684699. [PMID: 34163483 DOI: 10.3389/fimmu.2021.684699] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
15 Vonk MC, Walker UA, Volkmann ER, Kreuter M, Johnson SR, Allanore Y. Natural variability in the disease course of SSc-ILD: implications for treatment. Eur Respir Rev 2021;30:200340. [PMID: 33762426 DOI: 10.1183/16000617.0340-2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Ibrahim A, Ibrahim A, Parimon T. Diagnostic and Therapeutic Applications of Extracellular Vesicles in Interstitial Lung Diseases. Diagnostics (Basel) 2021;11:87. [PMID: 33430301 DOI: 10.3390/diagnostics11010087] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Türkkan G, Willems Y, Hendriks LEL, Mostard R, Conemans L, Gietema HA, Mitea C, Peeters S, De Ruysscher D. Idiopathic pulmonary fibrosis: Current knowledge, future perspectives and its importance in radiation oncology. Radiother Oncol 2021;155:269-77. [PMID: 33245945 DOI: 10.1016/j.radonc.2020.11.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
18 Avouac J, Cauvet A, Steelandt A, Shirai Y, Elhai M, Kuwana M, Distler O, Allanore Y. Improving risk-stratification of rheumatoid arthritis patients for interstitial lung disease. PLoS One 2020;15:e0232978. [PMID: 32384128 DOI: 10.1371/journal.pone.0232978] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]